Pharmalink elects Anders Wiklund as its new board chairman

pharmafile | November 23, 2011 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pharmalink 

Swedish speciality firm Pharmalink AB has elected Anders Wiklund to serve as its new chairman of the board.

In addition the firm has added the former chief executive and president of Diamyd, Elisabeth Lindner, to its board of directors.

Wiklund has gained a wealth of business and corporate development experience in the biotechnology and pharma industry from a career in Europe and the US, spanning 40 years.

He spent 29 years with the Kabi and Pharmacia group of companies, where he held a number of different positions, such as managing director of KabiVitrum in the UK, president of KabiVitrum International in Sweden, and president and chief executive of KabiVitrum and KabiPharmacia in the US.

Advertisement

Lindner is one of Sweden’s most experienced experts within the biopharmaceutical industry, with more than 25 years’ experience in senior management roles at Octapharma AB, Pharmacia Corporation and most recently as president and chief executive at Diamyd Medical.

Johan Häggblad, managing director of Pharmalink, said: “With Anders taking on the chairman’s role and Elisabeth joining the board, Pharmalink is positioned for the next stage of development.” 

Related Content

No items found
The Gateway to Local Adoption Series

Latest content